statins as protective agents for aortic endothelial cells
DESCRIPTION
Statins as Protective Agents for Aortic Endothelial Cells. Robert Kreisberg West Liberty State College. Our Facilities. WARNING!!. Experimental Design. - PowerPoint PPT PresentationTRANSCRIPT
Statins as Statins as Protective Protective Agents for Agents for
Aortic Aortic Endothelial Endothelial
CellsCellsRobert KreisbergRobert Kreisberg
West Liberty State CollegeWest Liberty State College
Our FacilitiesOur Facilities
WARNING!!
Experimental Experimental DesignDesign
To determine whether statins To determine whether statins inhibit IL-8 and VCAM production inhibit IL-8 and VCAM production in human aortic endothelial cells in human aortic endothelial cells (HAEC) in response to C-reactive (HAEC) in response to C-reactive protein (CRP), TNFa, and ox-LDL.protein (CRP), TNFa, and ox-LDL.
We will establish whether We will establish whether statins protect cultured statins protect cultured
HAECHAEC from injury induced from injury induced by:by:
C-reactive protein (CRP)C-reactive protein (CRP)
TNFα (10 ng/mL)TNFα (10 ng/mL)
ox-LDL (100 ug/ml) ox-LDL (100 ug/ml)
Injury will be monitored by Injury will be monitored by determining the levels of Il-determining the levels of Il-8 and VCAM-1 in HAEC by 8 and VCAM-1 in HAEC by immunoblotting, ELISA, immunoblotting, ELISA,
and RT-qPCRand RT-qPCR
MonocytesMonocytes
Role in the development of atherosclerotic Role in the development of atherosclerotic plaques (accumulation of lipids and plaques (accumulation of lipids and fibrous elements in the arteries)fibrous elements in the arteries)
Adhere to arterial walls, migrate Adhere to arterial walls, migrate through the layer of endothelial cells through the layer of endothelial cells and differentiate into macrophagesand differentiate into macrophages
Receptors on cell surface bind lipoprotein Receptors on cell surface bind lipoprotein particles, internalize them and accumulate particles, internalize them and accumulate lipid droplets, “foamy” appearancelipid droplets, “foamy” appearance
Foamy macrophages Foamy macrophages secrete:secrete:
proteolytic enzymes, degrade ECM---proteolytic enzymes, degrade ECM---resulting in formation of plaquesresulting in formation of plaques
reactive oxygen species (ROS) and reactive oxygen species (ROS) and Cytokines (TNFα, CRP, IL-6)Cytokines (TNFα, CRP, IL-6)
recruit more inflammatory cells into the recruit more inflammatory cells into the newly formed plaquesnewly formed plaques
increase lipid migration into the formed increase lipid migration into the formed plaqueplaque
C-reactive protein (CRP)C-reactive protein (CRP)
An acute phase response proteinAn acute phase response protein
Induces production of IL-8, TNFα, IL-6, and IL-1.Induces production of IL-8, TNFα, IL-6, and IL-1.
Increased levels are associated with higher risk of Increased levels are associated with higher risk of coronary heart diseasecoronary heart disease
Cell Adhesion Molecules Cell Adhesion Molecules
Hold tissues togetherHold tissues together Used by leukocytes to interact with tissue Used by leukocytes to interact with tissue
cellscells Increase the strength of the functional Increase the strength of the functional
interactions between cells of the immune systeminteractions between cells of the immune system
May be constitutively expressed or expressed only in May be constitutively expressed or expressed only in response to increases in local concentration of cytokines response to increases in local concentration of cytokines
Vascular Cell Adhesion Vascular Cell Adhesion Molecule (VCAM)Molecule (VCAM)
Member of the immunoglobulin superfamilyMember of the immunoglobulin superfamily
Expressed on vascular endothelial cellsExpressed on vascular endothelial cells
Little or no expression in resting human endotheliumLittle or no expression in resting human endothelium
Cell surface expression enhanced in inflamed tissue Cell surface expression enhanced in inflamed tissue
Function is to increase migration of monocytes, neutrophils, Function is to increase migration of monocytes, neutrophils, lymphocytes into inflamed tissue lymphocytes into inflamed tissue
TNFαTNFα Secreted by activated macrophagesSecreted by activated macrophages
Acts locally and systemicallyActs locally and systemically
Induces expression of VCAMInduces expression of VCAM Acts on macrophages and endothelial cells to induce Acts on macrophages and endothelial cells to induce
production of chemokines resulting in an influx of neutrophils)production of chemokines resulting in an influx of neutrophils)
Activates macrophages and neutrophilsActivates macrophages and neutrophils Increased phagocytosisIncreased phagocytosis Increased release of lytic enzymes into tissue spacesIncreased release of lytic enzymes into tissue spaces
Causes influx of eosinophils, basophils, neutrophils, monocytes, and mast cellsCauses influx of eosinophils, basophils, neutrophils, monocytes, and mast cells Participate in clearance of antigen and tissue healing Participate in clearance of antigen and tissue healing
IL-8 (Neutrophil Activating IL-8 (Neutrophil Activating Factor)Factor)
Produced by neutrophils and Produced by neutrophils and endothelial cellsendothelial cells
ChemoattractantChemoattractant Synergizes with IFN , TNF , GM-CSF Synergizes with IFN , TNF , GM-CSF
and G-CSFand G-CSF Enhances cytotoxic functions of Enhances cytotoxic functions of
neutrophilsneutrophils Enhances antibody-dependent Enhances antibody-dependent
cytotoxicitycytotoxicity Neutrophil recruitment across the Neutrophil recruitment across the
endothelium (concentration gradient)endothelium (concentration gradient)
StatinsStatins
Introduced in 1982 (Merck Introduced in 1982 (Merck Laboratories)Laboratories)
Inhibit 3-hydroxy-3-methylglutaryl Inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductasecoenzyme A reductase
Lower serum cholesterolLower serum cholesterol Successfully treat atherosclerosis Successfully treat atherosclerosis
and hypercholesterolemiaand hypercholesterolemia Attenuation of chronic inflammationAttenuation of chronic inflammation
Cholesterol SynthesisCholesterol SynthesisAcetyl-CoA
Numerous Rxns
Numerous Rxns
Cholesterol
Site of Restriction
Treatment Assay: Treatment Assay: Confluent cultures of HAECConfluent cultures of HAEC
CRP (50μg/ml) Ox-LDL (100μg/ml) TNFα (10ng/ml)
Lovastatin(0.1 to 50μmole/L)
X X X X X X
Mevalonate (200μM)
X X X X X X
Time span: 15min 24hr.
Cells treated with TNFCells treated with TNF
Cell lysate mRNA prep for RT-qPCR
At each time point:At each time point:
Supernatant IL-8 ELISA
Cell lysate VCAM immunoblotting
RT-qPCRRT-qPCR
-4.00
-2.00
0.00
2.00
4.00
6.00
8.00
10.00
15minutes
30minutes
60minutes
4 hours 8 hours
Lo
g f
old
ch
ang
e fr
om
zer
o ti
me
po
int
IL -8
V C A M
IL-8 ELISAIL-8 ELISAThe Expression of Il-8 from TNF-a
Treated Human Aortic Endothelial Cells
0
500
1000
1500
2000
2500
0 m
in
15 m
in
30m
in
60 m
in4
hrs
8 hr
s
24 h
rs
Time
Pe
rce
nt
(%)
Inc
rea
se
Supernatant %increase
Cellular Lysate% increase
SummarySummary
T.C. facilities are up-and –runningT.C. facilities are up-and –running Technician/students are trained in Technician/students are trained in
aseptic tissue-culture techniqueaseptic tissue-culture technique TNFα stimulates IL-8 and VCAM mRNA TNFα stimulates IL-8 and VCAM mRNA
productionproduction TNFα stimulates the production of IL-8 TNFα stimulates the production of IL-8
proteinprotein Production of VCAM protein between 8-Production of VCAM protein between 8-
24 hours has not been detected 24 hours has not been detected
ConcernsConcerns
$$$$$$$$
The Gang: Cassie, Amanda, Katie, and King The Gang: Cassie, Amanda, Katie, and King KreisbergKreisberg